Published on in Vol 11, No 11 (2022): November

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/40969, first published .
Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial

Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial

Physical Activity Program for the Survival of Elderly Patients With Lymphoma: Study Protocol for Randomized Phase 3 Trial

Jonas Dubu   1, 2, 3 * , MSc, PhD ;   Sébastien Boyas   2 * , PhD ;   Virginie Roland   4 * , MD ;   Sébastien Landry   1 * , MSc ;   Anne-Lise Septans   3 * , PhD ;   Magali Balavoine   3 * , MSc ;   Hugues Bourgeois   1 * , MD ;   Yoann Pointreau   1 * , MD ;   Fabrice Denis   1, 5 * , PhD, MD ;   Christophe Letellier   6 * , PhD ;   Katell Le Dû   7 * , MD

1 ELSAN, Institut inter-regional de Cancerologie Jean Bernard, Le Mans, France

2 Motricite Interactions Performance (MIP), UR4334, Le Mans Universite, Le Mans, France

3 WeproM, Le Mans, France

4 Hematology Department, Centre Hospitalier de Perpignan, Perpignan, France

5 Institut National de la e-Santé, Le Mans, France

6 CNRS UMR 6614 - CORIA, Rouen Normandie Universite, Saint Etienne du Rouvray, France

7 Hematology Department, Confluent Private Hospital, Nantes, France

*all authors contributed equally

Corresponding Author:

  • Jonas Dubu, MSc, PhD
  • ELSAN
  • Institut inter-regional de Cancerologie Jean Bernard
  • 9 rue Beauverger
  • Le Mans, 72000
  • France
  • Phone: 33 769510938
  • Email: j.dubu@ilcgroupe.fr